EUVIMEDOpdag EUVIMED
Crossref

Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats

Xuan Pan, Jianhai Wang, Shuo Liu, Ruonan Yu, Ziyu Li, Yumeng Zhang, Miao Wang iD, Chunjie Zhao iD, Min Zhao iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.6089 ↗

At a glance

Journal article in Biomedical Chromatography, 2025. Written by Xuan Pan and 8 co-authors. Institution: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China. Major MEDLINE topics: Hyperlipidemias, Drugs, Chinese Herbal, Metabolomics, Gastrointestinal Microbiome. Cited 1 times so far (Crossref); 59 references. Funded by: Applied Basic Research Program of the Department of Science and Technology of Liaoning Province, Basic Scientific Research Project of the Department of Education of Liaoning Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Sangge Jiangzhi pill, as a traditional Chinese medicine compound preparation, can be used to treat hyperlipidemia. However, the specific material basis and mechanism of action of the Sangge Jiangzhi pill are not clear. In this study, gut microbiota and host metabolism were investigated using 16S rRNA sequencing and metabolomics techniques. The changes in body weight, organ index, serum biochemical levels, and liver pathology demonstrated that the Sangge Jiangzhi pill reduced body weight and attenuated fat accumulation in hyperlipidemic rats. The results of gut microbiota analysis demonstrated that the Sangge Jiangzhi pill significantly enhanced the richness and diversity of gut microbiota in hyperlipidemia rats. Moreover, it regulated the relative abundance of Ligilactobacillus , Limosilactobacillus , Lactobacillus , Blautia , Parabacteroides , Helicobacter , Colidextribacter , Desulfovibrio , Rikenella , and Tuzzerella to protect the intestinal barrier and relieve the oxidative stress reaction. Metabonomics analysis showed that a total of 32 differential metabolites were identified in feces. The results of the correlation analysis revealed a significant association between intestinal microbiota and fecal metabolites. These results suggested that the Sangge Jiangzhi pill could achieve the purpose of treating hyperlipidemia by regulating gut microbiota imbalance and metabolic activity disorder.

Subjects

MeSH terms (MEDLINE)

HyperlipidemiasDrugs, Chinese HerbalMetabolomicsGastrointestinal MicrobiomeRNA, Ribosomal, 16SMetabolomeAnimalsRatsMaleRats, Sprague-DawleyFecesBacteria

Author keywords

Sangge Jiangzhi pillgut microbiotahyperlipidemiametabolomics

Substances

Drugs, Chinese HerbalRNA, Ribosomal, 16S

Authors and institutions

  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.
  • School of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.

ORCID profiles: Miao Wang, Chunjie Zhao, Min Zhao

Funding

  • Applied Basic Research Program of the Department of Science and Technology of Liaoning Province
  • Basic Scientific Research Project of the Department of Education of Liaoning Province

Cite

APA

Pan, X., Wang, J., Liu, S., Yu, R., Li, Z., Zhang, Y., Wang, M., Zhao, C., & Zhao, M. (2025). Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.6089

Vancouver

Pan X, Wang J, Liu S, Yu R, Li Z, Zhang Y, et al. Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats. Biomedical Chromatography. 2025. doi:10.1002/bmc.6089

BibTeX
@article{Pan2025,
  author = {Pan, Xuan and Wang, Jianhai and Liu, Shuo and Yu, Ruonan and Li, Ziyu and Zhang, Yumeng and Wang, Miao and Zhao, Chunjie and Zhao, Min},
  title = {Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.6089}
}
Start for free →